REZZAYO 200 mg powder for concentrate for solution for infusion

Licence status
Authorised: 22/12/2023
Active substances
Rezafungin acetate
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/23/1775/001
Licence holder
Mundipharma GmbH

Product documents

Licence information

ATC code
J02AX08 rezafungin acetate
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/12/2023